Tag: Sergio Santillana

Ikena Oncology gets FDA fast track designation for IK-930 in mesothelioma

pallavi123- June 23, 2022

Ikena Oncology has secured fast track designation for IK-930 from the US Food and Drug Administration in the treatment of unresectable NF2-deficient malignant pleural mesothelioma. ... Read More